OXAZEPAM
- Product NDC
- 69315-913
- 11-digit product format
- 693150913
- Labeler code
- 69315
- Product ID
- 69315-913_708e4237-a898-4d23-90b1-253c18301884
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXAZEPAM
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Leading Pharma, LLC
- Application
- ANDA218261
- Marketing category
- ANDA
- Marketing start
- 2025-07-09
- Substance
- OXAZEPAM
- Active strength
- 30 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OXAZEPAM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXAZEPAM | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6GOW6DWN2A |
| Rxcui | 198057, 198059, 312134 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69315-913-01 | OXAZEPAM | 100 in 1 BOTTLE | CAPSULE | 100 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69315-913-01 | 69315091301 | 100 CAPSULE in 1 BOTTLE (69315-913-01) | 100 capsule | 2025-07-09 | No | No | Historical |